XML 32 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2020 $ 7,346 $ 70,907,315 $ (43,785,085) $ 27,129,576
Balance (in shares) at Dec. 31, 2020 22,261,619      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 257,622 0 257,622
Issuance of common stock from 401K match $ 0 35,747 0 35,747
Issuance of common stock from 401K match (in shares) 16,642      
Net loss $ 0 0 (3,048,618) (3,048,618)
Balance at Mar. 31, 2021 $ 7,346 71,200,684 (46,833,703) 24,374,327
Balance (in shares) at Mar. 31, 2021 22,278,261      
Balance at Dec. 31, 2020 $ 7,346 70,907,315 (43,785,085) 27,129,576
Balance (in shares) at Dec. 31, 2020 22,261,619      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss       (16,918,477)
Balance at Dec. 31, 2021 $ 9,387 123,904,602 (60,703,562) 63,210,427
Balance (in shares) at Dec. 31, 2021 28,448,612      
Balance at Mar. 31, 2021 $ 7,346 71,200,684 (46,833,703) 24,374,327
Balance (in shares) at Mar. 31, 2021 22,278,261      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 441,598 0 441,598
Issuance of common stock from 401K match $ 5 (5) 0 0
Issuance of common stock from 401K match (in shares) 0      
Issuances of common stock, from exercise of stock options $ 17 220,586 0 220,603
Issuances of common stock, from exercise of stock options (in shares) 51,413      
Issuances of common stock, net of issuance costs $ 2,009 48,542,989 0 48,544,998
Issuances of common stock, net of issuance costs (in shares) 6,088,235      
Net loss $ 0 0 (588,931) (588,931)
Balance at Jun. 30, 2021 $ 9,377 120,405,851 (47,422,634) 72,992,594
Balance (in shares) at Jun. 30, 2021 28,417,909      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 1,701,763 0 1,701,763
Issuances of common stock, from exercise of stock options $ 6 123,501 0 123,507
Issuances of common stock, from exercise of stock options (in shares) 17,158      
Net loss $ 0 0 (6,960,966) (6,960,966)
Balance at Sep. 30, 2021 $ 9,383 122,231,115 (54,383,600) 67,856,898
Balance (in shares) at Sep. 30, 2021 28,435,067      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 1,673,475 0 1,673,475
Issuance of common stock from 401K match $ 4 12 0 16
Issuance of common stock from 401K match (in shares) 13,545      
Net loss $ 0 0 (6,319,962) (6,319,962)
Balance at Dec. 31, 2021 $ 9,387 123,904,602 (60,703,562) 63,210,427
Balance (in shares) at Dec. 31, 2021 28,448,612      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 1,128,973 0 1,128,973
Issuances of common stock, from exercise of stock options $ 1 7,487 0 7,488
Issuances of common stock, from exercise of stock options (in shares) 2,282      
Net loss $ 0 0 (8,473,522) (8,473,522)
Balance at Mar. 31, 2022 $ 9,388 125,041,062 (69,177,084) 55,873,366
Balance (in shares) at Mar. 31, 2022 28,450,894      
Balance at Dec. 31, 2021 $ 9,387 123,904,602 (60,703,562) 63,210,427
Balance (in shares) at Dec. 31, 2021 28,448,612      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuances of common stock, net of issuance costs       $ 9,900,000
Issuances of common stock, net of issuance costs (in shares)       1,238,491
Issuance of common stock for licensing agreement       $ 5,000,000
Net loss       (40,854,855)
Balance at Dec. 31, 2022 $ 9,956 145,550,491 (101,558,417) 44,002,030
Balance (in shares) at Dec. 31, 2022 30,170,317      
Balance at Mar. 31, 2022 $ 9,388 125,041,062 (69,177,084) 55,873,366
Balance (in shares) at Mar. 31, 2022 28,450,894      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 1,348,601 0 1,348,601
Issuances of common stock, from exercise of stock options $ 3 22,426 0 22,429
Issuances of common stock, from exercise of stock options (in shares) 7,794      
Net loss $ 0 0 (5,819,200) (5,819,200)
Balance at Jun. 30, 2022 $ 9,391 126,412,089 (74,996,284) 51,425,196
Balance (in shares) at Jun. 30, 2022 28,458,688      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 1,344,349 0 1,344,349
Issuance of warrants 0 1,713,741 0 1,713,741
Net loss 0 0 (7,424,450) (7,424,450)
Balance at Sep. 30, 2022 $ 9,391 129,470,179 (82,420,734) 47,058,836
Balance (in shares) at Sep. 30, 2022 28,458,688      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 0 1,374,233 0 1,374,233
Issuances of common stock, from exercise of stock options $ 89 1,563,756 0 1,563,845
Issuances of common stock, from exercise of stock options (in shares) 269,535      
Issuances of common stock, net of issuance costs $ 409 9,855,707 0 9,856,116
Issuances of common stock, net of issuance costs (in shares) 1,238,491      
Net shares for settlements of equity awards and taxes $ (58) (1,713,247) 0 (1,713,305)
Net shares for settlements of equity awards and taxes (in shares) (175,184)      
Issuance of common stock for licensing agreement $ 125 4,999,863 0 4,999,988
Issuance of common stock for licensing agreement (in shares) 378,787      
Net loss $ 0 0 (19,137,683) (19,137,683)
Balance at Dec. 31, 2022 $ 9,956 $ 145,550,491 $ (101,558,417) $ 44,002,030
Balance (in shares) at Dec. 31, 2022 30,170,317